Company intelligence / Profile preview
CellResearch Corporation
Singapore, Central Singapore, Singaporecellresearchcorp.com ↗
- Ownership
- Private
- Employees
- ~17
- Development stage
- Phase 1
01
Overview
CellResearch Corporation is a Singapore-based biotechnology company pioneering the use of umbilical cord lining-derived stem cells. It owns one of the world’s largest private skin/scar/keloid cell libraries and holds extensive IP on isolating both mesenchymal and epithelial stem cells from the umbilical cord lining. Its lead therapy for diabetic foot ulcers has entered Phase 1 USFDA clinical trials; additional pipeline programs target oncology, inflammatory disease, cardiac repair, neurodegeneration, ophthalmology, and diabetes at preclinical stages. The company also commercializes cosmeceuticals via its CALECIM brand using secreted proteins from red deer umbilical cord lining extract.
- Therapeutic areas
- OncologyEndocrinologyImmunologyCardiovascularOphthalmologyNeurology
- Modalities
- Stem cells (mesenchymal and epithelial, primarily from umbilical cord lining)Cellular therapiesSecreted cell proteins/extracts for cosmeceuticals
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with Harvard University for research purposesCollaborations with Procter & Gamble for research purposesCollaborations with Johnson & Johnson for research purposesCord blood banks license CordLabs technology
Beyond the preview
Go deeper on CellResearch Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CellResearch Corporation.